Shopping Cart

0

Your shopping bag is empty

Go to the shop

Publications

Publications

Sculptra Facial Plastic Surgery 2004 20; 2:157-163 Humble G, Mest, D. Soft Tissue Augmentation Using Silicone: An Historical Review Facial Plastic Surgery 2004 20; 2:181-184

Humble G, Filler Offers Longevity, Hope for Lipoatrophy Cosmetic Surgery Times 2005

Humble G, Treating Lipoatrophy with New Filler: A Look at Successful Patient Cases Skin & Aging 2004 Humble G, FDA Ponders Approval of New-Fill For Wrinkles, Volume Loss Dermatology Times 2003 Vol. 24 No. 9

Humble G, Mest D. Duration of Correction for Human Immunodeficiency Virus- Associated Lipoatrophy After Retreatment with Injectable Poly-L-Lactic Acid. Aesthetic Plast Surg 2009 33; 4:654

Humble G, Mest D. Retreatment with injectable PLLA for HIV-Associated Facial Lipoatrophy: 24-Month Extension of the Blue Pacific Study. Dermatol Surg 2009 35:350-359

Humble G, Mest D. A Recommended Approach to Cosmetic Enhancement with Sculptra. Skin & Aging 2007; 15 (10): 60-2

Humble G, Mest D, Conant M, Burgess, C. Poly-L-Lactic Acid for Facial Contouring: clinical insights

In Press

Humble G, Mest D, Safety and Efficacy of Poly-L-Lactic Acid (Sculptra) Injections in Persons with HIV-Associated Lipoatrophy: The US Experience: Dermatol Surg 2006 32; 11:1336-1345 

Humble G, Mest D, Human Immunodeficiency Virus-Associated Facial Lipoatrophy: A Review: Cosmetic Dermatology

2006 19; 1:62-66

Humble G, Mest D, Englehard P, Safety of Sculptra: A Review of Clinical Trial Data J Cosm Laser Ther 2005 7; 3-4:201-205

Humble G, Mest D. Evaluation of the Cross Fanning Injection Method for Injectable Poly L-Lactic acid for Treating HIV-Associated Facial Lipoatrophy (submitted)

Humble G, Mest D, Pierone G, Injectable Poly-L-Lactic Acid for Human Immunodeficiency Virus-Related Lipoatrophy: 1-Year Interim 5 Year Study Results, Summer AAD

Humble G, Mest D, Pierone G, Injectable Poly-L-Lactic Acid for Human Immunodeficiency Virus-Related Lipoatrophy: 2-Year Interim 5 Year Study Results, Summer AAD

Humble G, Mest D, Pierone G, Injectable Poly-L-Lactic Acid for Human Immunodeficiency Virus-Related Lipoatrophy: 3-Year Interim 5 Year Study Results, Summer AAD

Humble G, Mest D, Interim Results of a 5-Year Open-Label Study for the Correction of HIV-Related Facial Lipoatrophy with Injectable PLLA SDEF Hawaii Dermatology Meeting, Maui, HI 2009

Humble G, Mest D. Safety and Efficacy of Intradermal Poly-L-lactic acid (Sculptra) injections in patients with HIV- Associated Facial Lipoatrophy. Antiviral Therapy 2004; 9:L36

Humble G, Mest D. Poly L-Lactic Acid for the treatment of HIV-Associated Facial Lipoatrophy in Surgical Facial Rejuvenation: Art and Clinical Practice, Ed. Shiffman M, Springer, Berlin In Press

Humble G, Mest D. Review and Evaluation of Treatment Procedures Using Injectable Poly-L-Lactic Acid in the Treatment of HIV-Associated Facial Lipoatrophy Manuscript Submitted

Humble G, Mest D. Duration of Correction for Human Immunodeficiency Virus- Associated Lipoatrophy After Retreatment with Injectable Poly-L-Lactic Acid. Aesthetic Plastic Surgery In Press 2009 33; 4:654

Humble G, Mest D. Retreatment with injectable PLLA for HIV-Associated Facial Lipoatrophy: 24-Month Extension of the Blue Pacific Study. Dermatol Surg 2009 35:350-359

Humble G, Mest D. A Recommended Approach to Cosmetic Enhancement with Sculptra. Skin & Aging 2007; 15 (10): 60-2

Humble G, Mest D, Conant M, Burgess, C. Poly-L-Lactic Acid for Facial Contouring: clinical insights

In Press

Humble G, Mest D, Safety and Efficacy of Poly-L-Lactic Acid (Sculptra) Injections in Persons with HIV-Associated Lipoatrophy: The US Experience: Dermatol Surg 2006 32; 11:1336-1345

Humble G, Mest D, Human Immunodeficiency Virus-Associated Facial Lipoatrophy: A Review: Cosmetic Dermatology 2006 19; 1:62-66

Humble G, Mest D, Englehard P, Safety of Sculptra: A Review of Clinical Trial Data J Cosm Laser Therapy 2005 7; 3-4:201-205

Humble G, Mest D. Soft Tissue Augmentation Using Sculptra Facial Plastic Surgery 2004 20; 2:157- 163

Humble G, Mest D. Soft Tissue Augmentation Using Silicone: An Historical Review Facial Plastic Surgery 2004 20; 2:181-184

Scientific Publication authored by Gail Humble MD

Humble G, Bassichis B,Blick Conant M, Gold M, Echavez M, Mest D, Injectable Poly-L-Lactic Acid for Human Immunodeficiency Virus-Associated Facial Lipoatrophy: Cumulative 2 Year Interim Analysis of Open Label Study (Faces)American Society for Dermatologic Surgery, INC 2012;38:1193-1205

Humble G, Mest D. Evaluation of the Cross Fanning Injection Method for Injectable Poly L-lactic acid for Treating HIV-Associated Facial Lipoatrophy

Humble G, Mest D. Retreatment with Injectable Poly-L-Lactic Acid for HIV- Associated Facial Lipoatrophy: 24-Month Extension of the Blue Pacific Study. Dermatologic Surgery 2009 Vol. 35 No. 1 Sp ed. Feb 2009

Humble G, Mest D. Injection Method Review and Evaluation for Injectable Poly- L-Lactic Acid for Treating HIV-Associated Facial Lipoatrophy Manuscript Submitted

Humble G, Mest D. Duration of Correction of Human Immunodeficiency Virus- Associated Lipoatrophy Following Retreatment with Injectable Poly-L-Lactic Acid. Aesthetic Plastic Surgery in Press

Humble G, Mest D, Safety and Efficacy of Poly-L-Lactic Acid (Sculptra) injections in persons with HIV-Associated Lipoatrophy: The US Experience: Derm Surg 2006 32;11:1336-1345

Humble G, Mest D. Human Immunodeficiency Virus-Associated Facial Lipoatrophy: A Review: Cosmetic Dermatology 2006 19; 1:62-66

Humble G, Mest D, Englehard P. Safety of Sculptra: A Review of Clinical Trial Data Journal of Cosmetic Laser Therapy 2005

Humble G, Mest, D. Soft Tissue Augmentation Using Sculptra Facial Plastic Surgery 2004 20; 2:157-163 Humble G, Mest, D. Soft Tissue Augmentation Using Silicone: An Historical Review Facial Plastic Surgery 2004 20; 2:181-184

Humble G, Filler Offers Longevity, Hope for Lipoatrophy Cosmetic Surgery Times 2005

Humble G, Treating Lipoatrophy with New Filler

A Look at Successful Patient Cases Skin & Aging 2004 Humble G, FDA Ponders Approval of New-Fill For Wrinkles, Volume Loss Dermatology Times 2003 Vol. 24 No. 9

Humble G, Mest D. Duration of Correction for Human Immunodeficiency Virus- Associated Lipoatrophy After Retreatment with Injectable Poly-L-Lactic Acid. Aesthetic Plast Surg 2009 33; 4:654

Humble G, Mest D. Retreatment with injectable PLLA for HIV-Associated Facial Lipoatrophy: 24-Month Extension of the Blue Pacific Study. Dermatol Surg 2009 35:350-359

Humble G, Mest D. A Recommended Approach to Cosmetic Enhancement with Sculptra. Skin & Aging 2007; 15 (10): 60-2

Humble G, Mest D, Conant M, Burgess, C. Poly-L-Lactic Acid for Facial Contouring: clinical insights

In Press

Humble G, Mest D, Safety and Efficacy of Poly-L-Lactic Acid (Sculptra) Injections in Persons with HIV-Associated Lipoatrophy: The US Experience: Dermatol Surg 2006 32; 11:1336-1345

Humble G, Mest D, Human Immunodeficiency Virus-Associated Facial Lipoatrophy: A Review: Cosmetic Dermatology 2006 19; 1:62-66

Humble G, Mest D, Englehard P, Safety of Sculptra: A Review of Clinical Trial Data J Cosm Laser Ther 2005 7; 3-4:201-205

A NEW GENERATION OF SKINCARE

Register to receive news of our latest advances and products and enjoy 10% off your first order from Klotho Skin.